TPO and autoimmune thrombocytopenic purpura: Moreover, corticosteroids and intravenous immunoglobulin (IVIG) are still the first‐line treatment options for COVID‐related ITP, but TPO‐RA is merely reserved for refractory ITP due to its risks, such as hepatotoxicity and thrombosis.